. Author manuscript; available in PMC: 2018 Mar 30.

Published in final edited form as: Int J Obes (Lond). 2017 Sep 25;42(3):302–309. doi: 10.1038/ijo.2017.233

Table 2.

Development of metabolic complications in metabolically healthy normal weight (MHNW) and metabolically healthy overweight or obese (MHO) according to weight gain percent

Percent weight gain	MHNW N^a (%)	Odds ratio^b (95% CI)	MHO N^a (%)	Odds ratio (95% CI)
≤ 0%^c	211(64%)		270 (76%)
>0 & <5%	183 (67%)	1.17 (0.81–1.69)	153 (79%)	1.30 (0.83–2.07)
5–10%	169 (68%)	1.45 (0.99–2.13)	131 (80%)	1.43 (0.89–2.33)
10–15%	115 (61%)	1.23 (0.82–1.86)	121 (85%)	2.39 (1.39–4.25)
>15%	282 (74%)	2.96 (2.05–4.29)	178 (81%)	2.47 (1.57–3.96)

N refers to number of individuals that developed metabolic complications.

Model adjusted for age at baseline, sex, BMI at baseline, time of follow up and smoking status, chronic kidney disease, chronic liver disease, chronic obstructive pulmonary disease, malignancy.

Reference group used for estimation of odds ratio.

Elopment ss <0% of their initiaoc complication in those that loss 0–5% of their body weight compared to those that loss <0% of tMetabolic complications were defined as the development of any of the components of the metabolic syndrome (except for waist circumference) or diagnosis of cardiovascular disease, heart failure or diabetes at least at 8 years follow up.